Clinical benefits of pegylated proteins in oncology

This publication has 6 references indexed in Scilit:

• Improvements in protein PEGylation: pegylated interferons for treatment of hepatitis C
  Journal of Controlled Release, 2001
• Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma
  European Journal Of Cancer, 2001
• Randomized, Dose-Escalation Study of SD/01 Compared With Daily Filgrastim in Patients Receiving Chemotherapy
  Journal of Clinical Oncology, 2000
• Controlled-Release, Pegylation, Liposomal Formulations: New Mechanisms in the Delivery of Injectable Drugs
  Annals of Pharmacotherapy, 2000
• Polyethylene glycol-conjugated pharmaceutical proteins
  Pharmaceutical Science & Technology Today, 1998
• Doxorubicin Encapsulated in Liposomes Containing Surface‐Bound Polyethylene Glycol: Pharmacokinetics, Tumor Localization, and Safety in Patients with AIDS‐Related Kaposi's Sarcoma
  The Journal of Clinical Pharmacology, 1996